09:47 AM EDT, 03/17/2025 (MT Newswires) -- China Sxt Pharmaceuticals ( SXTC ) said Monday that it has regained compliance with Nasdaq's minimum bid price listing requirement.
The pharmaceutical company said it regained compliance as its stock price was at least $1 a share for 10 consecutive business days ending March 12.
Shares were up 1.8% in early trading.